[1]Bárány,Péter;Oláh,RitaSzabó;Kovács,Imre;Czuczi,Tamás;Szabó,CsengeLilla;Takács,Angéla;Lajkó,Eszter;Láng,Orsolya;Ohidai,LászlóK.;Schlosser,Gitta;Osze,SzilviaB.;Mezo,Gábor;Hudecz,Ferenc;Csámpai,Antal[Molecules,2018,vol.23,#9]
[1]Bárány,Péter;Oláh,RitaSzabó;Kovács,Imre;Czuczi,Tamás;Szabó,CsengeLilla;Takács,Angéla;Lajkó,Eszter;Láng,Orsolya;Ohidai,LászlóK.;Schlosser,Gitta;Osze,SzilviaB.;Mezo,Gábor;Hudecz,Ferenc;Csámpai,Antal[Molecules,2018,vol.23,#9]
[1]CurrentPatentAssignee:SHAANXINORMALUNIVERSITY-CN115477613,2022,ALocationinpatent:Paragraph0097-0099
Title: Fatty acid and carbohydrate storage in the annual reproductive cyclice of Echinaster.
Journal: Comparative biochemistry and physiology. A, Comparative physiology 19751201
Title: Takenobu Nii, et al. The Novel Imipridone ONC212 Induces Pronounced Anti-Leukemia Effects in Vitro and In Vivo and Is Highly Synergistic with the BCL-2 Inhibitor ABT-199. ASH. 2017.
Title: Lev A, et al. Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP. Oncotarget. 2017 Sep 12;8(47):81776-81793.
Title: Wagner J, et al. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212. Cell Cycle. 2017 Oct 2;16(19):1790-1799.
